136 related articles for article (PubMed ID: 8667223)
1. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
Cushing DJ; Zgombick JM; Nelson DL; Cohen ML
J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
3. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
[TBL] [Abstract][Full Text] [Related]
5. Serotonin-induced relaxation in canine coronary artery smooth muscle.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1992 Oct; 263(1):123-9. PubMed ID: 1403777
[TBL] [Abstract][Full Text] [Related]
6. The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype.
Terrón JA
Br J Pharmacol; 1996 Jul; 118(6):1421-8. PubMed ID: 8832067
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the relaxant 5-HT receptor in the dog basilar artery by the high-affinity 5-HT7 receptor ligand, LY215840.
Terrón JA
Proc West Pharmacol Soc; 1998; 41():129-30. PubMed ID: 9836268
[No Abstract] [Full Text] [Related]
8. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
Pertz HH; Milhahn H; Eich E
J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries.
Terrón JA; Falcón-Neri A
Br J Pharmacol; 1999 Jun; 127(3):609-16. PubMed ID: 10401550
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.
Janssen P; Prins NH; Meulemans AL; Lefebvre RA
Br J Pharmacol; 2002 May; 136(2):321-9. PubMed ID: 12010782
[TBL] [Abstract][Full Text] [Related]
12. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
Kauffman RF; Bean JS; Bloomquist WE; Cohen ML
J Pharmacol Exp Ther; 1993 Jul; 266(1):450-5. PubMed ID: 8331571
[TBL] [Abstract][Full Text] [Related]
13. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
[TBL] [Abstract][Full Text] [Related]
14. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
Cohen ML; Colbert WE
J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
[TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
Cohen ML; Parli CJ; Fuller RW
J Pharmacol Exp Ther; 1989 Dec; 251(3):1006-11. PubMed ID: 2600800
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.
Irving HR; Tan YY; Tochon-Danguy N; Liu H; Chetty N; Desmond PV; Pouton CW; Coupar IM
Life Sci; 2007 Mar; 80(13):1198-205. PubMed ID: 17258778
[TBL] [Abstract][Full Text] [Related]
19. Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs.
Jähnichen S; Glusa E; Pertz HH
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):89-98. PubMed ID: 15726452
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
